ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

SABSW SAB Biotherapeutics Inc

0.0399
-0.0001 (-0.25%)
2024年6月18日 - 終了
15分遅延
名称 銘柄コード 市場 種別
SAB Biotherapeutics Inc SABSW NASDAQ Equity Warrant
  前日比 前日比 % 現在値 時刻
-0.0001 -0.25% 0.0399 06:45:13
始値 安値 高値 終値 前日終値
0.04 0.0399 0.0449 0.0399 0.04
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3106:15EDGAR2Form DEF 14A - Other definitive proxy statements
2024/5/2120:30EDGAR2Form 8-K - Current report
2024/5/2106:45GLOBESAB Biotherapeutics Announces Q1 2024 Financial Results and..
2024/5/2105:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0620:15GLOBESAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of..
2024/4/1620:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
2024/4/0820:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
2024/4/0420:15GLOBESAB Biotherapeutics to Present at the Needham Virtual..
2024/3/2920:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and..
2024/3/2523:15GLOBESAB Biotherapeutics Announces Clinical Partnership with..
2024/2/2322:00GLOBESAB Biotherapeutics to Present at the BIO CEO & Investor..
2024/2/0822:00GLOBESAB Biotherapeutics to Present at the Oppenheimer..
2024/2/0221:30GLOBESAB Biotherapeutics Announces Executive Leadership Change
2024/1/2407:58GLOBESAB Biotherapeutics Regains Compliance with Nasdaq Minimum..
2024/1/0306:30GLOBESAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
2023/11/2921:30GLOBESAB Biotherapeutics Announces Commencement of the HUMAN..
2023/11/2021:30GLOBESAB Biotherapeutics Appoints Katie Ellias to the Board of..
2023/11/1421:30GLOBESAB Biotherapeutics Announces Completion of $67.1 Million..
2023/11/1421:15GLOBESAB Biotherapeutics Announces Q3 2023 Financial Results and..
2023/11/0921:30GLOBESAB Biotherapeutics to Present at Piper Sandler Healthcare..
2023/10/2420:30GLOBESAB Biotherapeutics Appoints Michael G. King Jr. as Chief..
2023/10/1920:30GLOBESAB Biotherapeutics Receives Australian Approval to Commence..
2023/10/0520:30GLOBESAB Biotherapeutics Approves Appointment of Andrew Moin to..
2023/10/0220:30GLOBESAB Biotherapeutics Announces Private Placement of up to..
2023/8/2121:30GLOBESAB Biotherapeutics Provides Company Update for Q2..
2023/6/2121:30GLOBESAB Biotherapeutics Presents Positive IND-Enabling GLP..

最近閲覧した銘柄

Delayed Upgrade Clock